SHARON BENZENO Insider Trading $ADPT Adaptive Biotechnologies Corp

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for SHARON BENZENO.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of SHARON BENZENO. SHARON BENZENO is Chief Business Development Off in Adaptive Biotechnologies Corp ($ADPT) and SVP, Drug Discovery in Adaptive Biotechnologies Corp ($ADPT).

SHARON BENZENO in Adaptive Biotechnologies Corp

Trading Symbol: ADPT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SHARON BENZENO: Chief Business Development Off, SVP, Drug Discovery
Holdings: 22,894 shares
Latest Transaction: Mar 08 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of SHARON BENZENO in Adaptive Biotechnologies Corp

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 08 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	A	43.68	57,234	2,499,981	57,234
Mar 08 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Grant	A	0.00	22,894	0	22,894	0 to 22.9 K
Feb 17 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	31.71	16,250	515,288	48,750
Feb 17 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	65.29	9,528	622,083	0	9.5 K to 0 (-100.00 %)
Feb 17 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	64.59	1,700	109,803	9,528	11.2 K to 9.5 K (-15.14 %)
Feb 17 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	63.42	5,022	318,495	11,228	16.3 K to 11.2 K (-30.90 %)
Feb 17 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	31.71	16,250	515,288	16,250	0 to 16.3 K
Feb 03 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	7.27	1,562	11,356	35,938
Feb 03 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	52,084
Feb 03 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	23,438
Feb 03 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	56.41	300	16,923	0	300 to 0 (-100.00 %)
Feb 03 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	55.61	6,470	359,797	300	6.8 K to 300 (-95.57 %)
Feb 03 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	7.27	1,562	11,356	6,770	5.2 K to 6.8 K (+29.99 %)
Feb 03 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	5,208	2.6 K to 5.2 K (+100.00 %)
Feb 03 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	2,604	0 to 2.6 K
Jan 20 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.27	417	2,615	1,250
Jan 20 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	69.00	417	28,773	0	417 to 0 (-100.00 %)
Jan 20 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.27	417	2,615	417	0 to 417
Jan 06 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	7.27	1,563	11,363	37,500
Jan 06 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	54,688
Jan 06 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	26,042
Jan 06 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	59.46	267	15,876	0	267 to 0 (-100.00 %)
Jan 06 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	58.63	495	29,022	267	762 to 267 (-64.96 %)
Jan 06 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	57.82	3,800	219,716	762	4.6 K to 762 (-83.30 %)
Jan 06 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	56.12	2,209	123,969	4,562	6.8 K to 4.6 K (-32.62 %)
Jan 06 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	7.27	1,563	11,363	6,771	5.2 K to 6.8 K (+30.01 %)
Jan 06 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	5,208	2.6 K to 5.2 K (+100.00 %)
Jan 06 2021	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	2,604	0 to 2.6 K
Dec 23 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.27	417	2,615	1,667
Dec 23 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	59.14	417	24,661	0	417 to 0 (-100.00 %)
Dec 23 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.27	417	2,615	417	0 to 417
Dec 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	7.27	1,562	11,356	39,063
Dec 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	57,292
Dec 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	28,646
Dec 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	49.43	3,693	182,545	0	3.7 K to 0 (-100.00 %)
Dec 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	48.20	3,077	148,311	3,693	6.8 K to 3.7 K (-45.45 %)
Dec 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	7.27	1,562	11,356	6,770	5.2 K to 6.8 K (+29.99 %)
Dec 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	5,208	2.6 K to 5.2 K (+100.00 %)
Dec 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	2,604	0 to 2.6 K
Nov 23 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.27	416	2,608	2,084
Nov 23 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	48.86	416	20,326	0	416 to 0 (-100.00 %)
Nov 23 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.27	416	2,608	416	0 to 416
Nov 04 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	7.27	1,563	11,363	40,625
Nov 04 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	59,896
Nov 04 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,605	17,063	31,250
Nov 04 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	46.14	1,074	49,554	0	1.1 K to 0 (-100.00 %)
Nov 04 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	45.47	5,698	259,088	1,074	6.8 K to 1.1 K (-84.14 %)
Nov 04 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	7.27	1,563	11,363	6,772	5.2 K to 6.8 K (+30.01 %)
Nov 04 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	5,209	2.6 K to 5.2 K (+99.96 %)
Nov 04 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,605	17,063	2,605	0 to 2.6 K
Oct 20 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.27	417	2,615	2,500
Oct 20 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	51.25	417	21,371	0	417 to 0 (-100.00 %)
Oct 20 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.27	417	2,615	417	0 to 417
Oct 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	7.27	1,562	11,356	42,188
Oct 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,605	17,063	62,500
Oct 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	33,855
Oct 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	49.26	893	43,989	0	893 to 0 (-100.00 %)
Oct 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	48.46	5,878	284,848	893	6.8 K to 893 (-86.81 %)
Oct 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	7.27	1,562	11,356	6,771	5.2 K to 6.8 K (+29.99 %)
Oct 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,605	17,063	5,209	2.6 K to 5.2 K (+100.04 %)
Oct 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	2,604	0 to 2.6 K
Sep 23 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.27	417	2,615	2,917
Sep 23 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	45.51	417	18,978	0	417 to 0 (-100.00 %)
Sep 23 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.27	417	2,615	417	0 to 417
Sep 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	7.27	1,563	11,363	43,750
Sep 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	65,105
Sep 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	36,459
Sep 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	41.75	300	12,525	0	300 to 0 (-100.00 %)
Sep 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	41.28	6,471	267,123	300	6.8 K to 300 (-95.57 %)
Sep 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	7.27	1,563	11,363	6,771	5.2 K to 6.8 K (+30.01 %)
Sep 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	5,208	2.6 K to 5.2 K (+100.00 %)
Sep 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	2,604	0 to 2.6 K
Aug 19 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.27	416	2,608	3,334
Aug 19 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	41.57	416	17,293	0	416 to 0 (-100.00 %)
Aug 19 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.27	416	2,608	416	0 to 416
Aug 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.32	417	2,635	0
Aug 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	7.27	1,562	11,356	45,313
Aug 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	67,709
Aug 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	39,063
Aug 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	40.00	7,187	287,480	0	7.2 K to 0 (-100.00 %)
Aug 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.32	417	2,635	7,187	6.8 K to 7.2 K (+6.16 %)
Aug 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	7.27	1,562	11,356	6,770	5.2 K to 6.8 K (+29.99 %)
Aug 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	5,208	2.6 K to 5.2 K (+100.00 %)
Aug 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	2,604	0 to 2.6 K
Jul 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.27	417	2,615	3,750
Jul 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	40.00	417	16,680	0	417 to 0 (-100.00 %)
Jul 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.27	417	2,615	417	0 to 417
Jul 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	7.27	1,563	11,363	46,875
Jul 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	70,313
Jul 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	41,667
Jul 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	48.13	1,200	57,756	0	1.2 K to 0 (-100.00 %)
Jul 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	47.17	5,571	262,784	1,200	6.8 K to 1.2 K (-82.28 %)
Jul 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	7.27	1,563	11,363	6,771	5.2 K to 6.8 K (+30.01 %)
Jul 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	5,208	2.6 K to 5.2 K (+100.00 %)
Jul 02 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	2,604	0 to 2.6 K
Jul 01 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.32	417	2,635	417
Jul 01 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	47.42	417	19,774	0	417 to 0 (-100.00 %)
Jul 01 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.32	417	2,635	417	0 to 417
Jun 30 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.32	417	2,635	417
Jun 30 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	47.42	417	19,774	0	417 to 0 (-100.00 %)
Jun 30 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.32	417	2,635	417	0 to 417
Jun 23 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.27	417	2,615	4,167
Jun 23 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	45.00	417	18,765	0	417 to 0 (-100.00 %)
Jun 23 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.27	417	2,615	417	0 to 417
Jun 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	7.27	1,562	11,356	48,438
Jun 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	72,917
Jun 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	2,604	17,056	43,271
Jun 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	40.00	6,770	270,800	0	6.8 K to 0 (-100.00 %)
Jun 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	7.27	1,562	11,356	6,770	5.2 K to 6.8 K (+29.99 %)
Jun 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	5,208	2.6 K to 5.2 K (+100.00 %)
Jun 05 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	2,604	17,056	2,604	0 to 2.6 K
May 28 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.32	416	2,629	834
May 28 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	42.00	416	17,472	0	416 to 0 (-100.00 %)
May 28 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.32	416	2,629	416	0 to 416
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	7.27	25,000	181,750	50,000
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	49,479	324,087	75,521
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	78,125	511,719	45,875
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.27	15,416	96,658	4,584
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.32	18,750	118,500	1,250
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	1.98	60,000	118,800	0
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	40.00	246,770	9,870,800	0	246.8 K to 0 (-100.00 %)
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	7.27	25,000	181,750	246,770	221.8 K to 246.8 K (+11.27 %)
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	49,479	324,087	221,770	172.3 K to 221.8 K (+28.72 %)
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	78,125	511,719	172,291	94.2 K to 172.3 K (+82.97 %)
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.27	15,416	96,658	94,166	78.8 K to 94.2 K (+19.58 %)
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.32	18,750	118,500	78,750	60 K to 78.8 K (+31.25 %)
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	1.98	60,000	118,800	60,000	0 to 60 K
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	7.27	25,000	181,750	50,000
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	49,479	324,087	75,521
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.55	78,125	511,719	45,875
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.27	15,416	96,658	4,584
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	6.32	18,750	118,500	1,250
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Option Exercise	M	1.98	60,000	118,800	0
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Sell	S	40.00	246,770	9,870,800	0	246.8 K to 0 (-100.00 %)
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	7.27	25,000	181,750	246,770	221.8 K to 246.8 K (+11.27 %)
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	49,479	324,087	221,770	172.3 K to 221.8 K (+28.72 %)
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.55	78,125	511,719	172,291	94.2 K to 172.3 K (+82.97 %)
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.27	15,416	96,658	94,166	78.8 K to 94.2 K (+19.58 %)
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	6.32	18,750	118,500	78,750	60 K to 78.8 K (+31.25 %)
May 21 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	Chief Business Deve ...	Buy	M	1.98	60,000	118,800	60,000	0 to 60 K
Feb 18 2020	ADPT	Adaptive Biotechno ...	BENZENO SHARON	SVP, Drug Discovery	Option Exercise	A	31.71	65,000	2,061,150	65,000

Page: 1